Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines

Neuroscience Letters

Volumn 367, Issue 3, 2004, Pages 349-354

  Thomas, David M ^a,b   Dowgiert, Jennifer ^a   Geddes, Timothy J ^a,b   Francescutti Verbeem, Dina ^a   Liu, Xiuli ^a   Kuhn, Donald M ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

MDMA; Methamphetamine; Microglia; Neurotoxicity; Striatum

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; AMPHETAMINE; CYTOKINE; DEXAMPHETAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; METHAMPHETAMINE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; MICROGLIA; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC MEMBRANE;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CELL COUNT; CORPUS STRIATUM; DOPAMINE AGENTS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; LECTINS; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICROGLIA; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; P-CHLOROAMPHETAMINE;

EID: 4444335318     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.06.065     Document Type: Article

References (59)

1. F. Aloisi Immune function of microglia Glia 36 2001 165 179
2. V. Armstrong, C.M. Reichel, J.F. Doti, C.A. Crawford, and S.A. McDougall Repeated amphetamine treatment causes a persistent elevation of glial fibrillary acidic protein in the caudate-putamen Eur. J. Pharmacol. 488 2004 111 115
3. A.E. Ayoub, and A.K. Salm Increased morphological diversity of microglia in the activated hypothalamic supraoptic nucleus J. Neurosci. 23 2003 7759 7766
4. C. Bendotti, S. Baldessari, M. Pende, G. Tarizzo, A. Miari, M.L. Presti, T. Mennini, and R. Samanin Does GFAP mRNA and mitochondrial benzodiazepine receptor binding detect serotonergic neuronal degeneration in rat? Brain Res. Bull. 34 1994 389 394
5. J.F. Bowyer Neuronal degeneration in the limbic system of weanling rats exposed to saline, hyperthermia or d-amphetamine Brain Res. 885 2000 166 171
6. J.F. Bowyer, D.L. Davies, L. Schmued, H.W. Broening, G.D. Newport, W. Slikker Jr., and R.R. Holson Further studies of the role of hyperthermia in methamphetamine neurotoxicity J. Pharmacol. Exp. Ther. 268 1994 1571 1580
7. J.L. Cadet, S. Jayanthi, and X. Deng Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis FASEB J. 17 2003 1775 1788
8. A. Czlonkowska, M. Kohutnicka, I. Kurkowska-Jastrzebska, and A. Czlonkowski Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) induced Parkinson's disease mice model Neurodegeneration 5 1996 137 143
9. C. Davidson, A.J. Gow, T.H. Lee, and E.H. Ellinwood Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment Brain Res. Brain Res. Rev. 36 2001 1 22
10. A.M. Depino, C. Earl, E. Kaczmarczyk, C. Ferrari, H. Besedovsky, A. del Rey, F.J. Pitossi, and W.H. Oertel Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease Eur. J. Neurosci. 18 2003 2731 2742
11. Y. Du, Z. Ma, S. Lin, R.C. Dodel, F. Gao, K.R. Bales, L.C. Triarhou, E. Chernet, K.W. Perry, D.L. Nelson, S. Luecke, L.A. Phebus, F.P. Bymaster, and S.M. Paul Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease Proc. Natl. Acad. Sci. USA 98 2001 14669 14674
12. E. Escubedo, L. Guitart, F.X. Sureda, A. Jimenez, D. Pubill, M. Pallas, A. Camins, and J. Camarasa Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats Brain Res. 814 1998 120 126
13. H.M. Gao, J.S. Hong, W. Zhang, and B. Liu Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons J. Neurosci. 22 2002 782 790
14. P.J. Gebicke-Haerter Microglia in neurodegeneration: molecular aspects Microsc. Res. Tech. 54 2001 47 58
15. P.J. Gebicke-Haerter, O. Spleiss, L.Q. Ren, H. Li, S. Dichmann, J. Norgauer, and H.W. Boddeke Microglial chemokines and chemokine receptors Prog. Brain Res. 132 2001 525 532
16. J.W. Gibb, M. Johnson, I. Elayan, H.K. Lim, L. Matsuda, and G.R. Hanson Neurotoxicity of amphetamines and their metabolites NIDA Res. Monogr. 173 1997 128 145
17. F. Gonzalez-Scarano, and G. Baltuch Microglia as mediators of inflammatory and degenerative diseases Annu. Rev. Neurosci. 22 1999 219 240
18. T.R. Guilarte, M.K. Nihei, J.L. McGlothan, and A.S. Howard Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity Neuroscience 122 2003 499 513
19. U.K. Hanisch Microglia as a source and target of cytokines Glia 40 2002 140 155
20. Y. He, S. Appel, and W. Le Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum Brain Res. 909 2001 187 193
21. Y. Itzhak, C.N. Achat-Mendes, S.F. Ali, and K.L. Anderson Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine- induced neurotoxicity in mice Neuropharmacology 46 2004 74 84
22. R.L. Jakab, and J.F. Bowyer Parvalbumin neuron circuits and microglia in three dopamine-poor cortical regions remain sensitive to amphetamine exposure in the absence of hyperthermia, seizure and stroke Brain Res. 958 2002 52 69
23. E.A. Johnson, J.P. O'Callaghan, and D.B. Miller Brain concentrations of d-MDMA are increased after stress Psychopharmacology (Berl.) 173 2004 278 286
24. K.L. Johnson-Davis, J.G. Truong, A.E. Fleckenstein, and D.G. Wilkins Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine J. Pharmacol. Exp. Ther. 309 2004 578 586
25. I.N. Krasnova, B. Ladenheim, S. Jayanthi, J. Oyler, T.H. Moran, M.A. Huestis, and J.L. Cadet Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice: complex roles for oxygen-based species and temperature regulation Neuroscience 107 2001 265 274
26. G.W. Kreutzberg Microglia: a sensor for pathological events in the CNS Trends Neurosci. 19 1996 312 318
27. M.J. LaVoie, J.P. Card, and T.G. Hastings Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity Exp. Neurol. 187 2004 47 57
28. S. Lehnardt, L. Massillon, P. Follett, F.E. Jensen, R. Ratan, P.A. Rosenberg, J.J. Volpe, and T. Vartanian Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway Proc. Natl. Acad. Sci. USA 100 2003 8514 8519
29. J. Lyles, and J.L. Cadet Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms Brain Res. Brain Res. Rev. 42 2003 155 168
30. U.D. McCann, D.F. Wong, F. Yokoi, V. Villemagne, R.F. Dannals, and G.A. Ricaurte Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428 J. Neurosci. 18 1998 8417 8422
31. U.D. McCann, J. Yuan, and G.A. Ricaurte Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain Synapse 30 1998 239 246
32. D.B. Miller, and J.P. O'Callaghan Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse J. Pharmacol. Exp. Ther. 270 1994 752 760
33. D.B. Miller, and J.P. O'Callaghan The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine Mol. Neurobiol. 11 1995 177 192
34. D.B. Miller, and J.P. O'Callaghan Neurotoxicity of d-amphetamine in the C57BL/6J and CD-1 mouse. Interactions with stress and the adrenal system Ann. N.Y. Acad. Sci. 801 1996 148 167
35. S. Moore, and S. Thanos The concept of microglia in relation to central nervous system disease and regeneration Prog. Neurobiol. 48 1996 441 460
36. M.D. Nguyen, J.P. Julien, and S. Rivest Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci. 3 2002 216 227
37. J.P. O'Callaghan, and D.B. Miller Quantification of reactive gliosis as an approach to neurotoxicity assessment NIDA Res. Monogr. 136 1993 188 212
38. J.P. O'Callaghan, and D.B. Miller Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse J. Pharmacol. Exp. Ther. 270 1994 741 751
39. J.P. O'Callaghan, and D.B. Miller Brain serotonin neurotoxicity and fenfluramine and dexfenfluramine [letter; comment] J. Am. Med. Assoc. 278 1997 2141 2142 (discussion 2142)
40. J.M. Pocock, and A.C. Liddle Microglial signalling cascades in neurodegenerative disease Prog. Brain Res. 132 2001 555 565
41. C. Pu, H.W. Broening, and C.V. Vorhees Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex Synapse 23 1996 328 334
42. C. Pu, and C.V. Vorhees Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum Brain Res. Dev. Brain Res. 72 1993 325 328
43. D. Pubill, A.M. Canudas, M. Pallas, A. Camins, J. Camarasa, and E. Escubedo Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity Naunyn Schmiedebergs Arch. Pharmacol. 367 2003 490 499
44. D. Pubill, E. Verdaguer, F.X. Sureda, A. Camins, M. Pallas, J. Camarasa, and E. Escubedo Carnosine prevents methamphetamine-induced gliosis but not dopamine terminal loss in rats Eur. J. Pharmacol. 448 2002 165 168
45. S. Rose, S. Hunt, P. Collins, J.G. Hindmarsh, and P. Jenner Repeated administration of escalating high doses of dexfenfluramine does not produce morphological evidence for neurotoxicity in the cortex of rats Neurodegeneration 5 1996 145 152
46. R.B. Rothman, S. Jayanthi, X. Wang, C.M. Dersch, J.L. Cadet, T. Prisinzano, K.C. Rice, and M.H. Baumann High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain Synapse 50 2003 233 239
47. N.E. Rowland, A.N. Kalehua, B.H. Li, S.L. Semple-Rowland, and W.J. Streit Loss of serotonin uptake sites and immunoreactivity in rat cortex after dexfenfluramine occur without parallel glial cell reactions Brain Res. 624 1993 35 43
48. Y. Sekine, M. Iyo, Y. Ouchi, T. Matsunaga, H. Tsukada, H. Okada, E. Yoshikawa, M. Futatsubashi, N. Takei, and N. Mori Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET Am. J. Psychiatry 158 2001 1206 1214
49. T.B. Sherer, R. Betarbet, J.H. Kim, and J.T. Greenamyre Selective microglial activation in the rat rotenone model of Parkinson's disease Neurosci. Lett. 341 2003 87 90
50. C.W. Stewart, and W. Slikker Jr. Hyperthermia-enhanced serotonin (5-HT) depletion resulting from d-fenfluramine (d-Fen) exposure does not evoke a glial-cell response in the central nervous system of rats Brain Res. 839 1999 279 282
51. W.J. Streit An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4) J. Histochem. Cytochem. 38 1990 1683 1686
52. W.J. Streit Microglia as neuroprotective, immunocompetent cells of the CNS Glia 40 2002 133 139
53. D.M. Thomas, D.M. Francescutti-Verbeem, X. Liu, and D.M. Kuhn Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment - an oligonucleotide microarray approach J. Neurochem. 88 2004 380 393
54. D.M. Thomas, P.D. Walker, J.A. Benjamins, T.J. Geddes, D.M. Kuhn, Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation, J. Pharmacol. Exp. Ther. (2004) (Epub ahead of print as DOI: 10.1124/jpet.104.070961).
55. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, M. Leonido-Yee, D. Franceschi, M.J. Sedler, S.J. Gatley, R. Hitzemann, Y.S. Ding, J. Logan, C. Wong, and E.N. Miller Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers Am. J. Psychiatry 158 2001 377 382
56. M.T. Williams, L.L. Morford, A.E. McCrea, S.L. Inman-Wood, and C.V. Vorhees Elevations in plasmatic titers of corticosterone and aldosterone, in the absence of changes in ACTH, testosterone, or glial fibrillary acidic protein, 72 h following d,l-fenfluramine or d-fenfluramine administration to rats Neurotoxicol. Teratol. 23 2001 23 32
57. M.A. Wilson, and M.E. Molliver Microglial response to degeneration of serotonergic axon terminals Glia 11 1994 18 34
58. D.C. Wu, V. Jackson-Lewis, M. Vila, K. Tieu, P. Teismann, C. Vadseth, D.K. Choi, H. Ischiropoulos, and S. Przedborski Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson disease J. Neurosci. 22 2002 1763 1771
59. T. Wyss-Coray, and L. Mucke Inflammation in neurodegenerative disease - a double-edged sword Neuron 35 2002 419 432